期刊文献+

甲状腺功能亢进的糖尿病患者生化指标变化

Biochemical parameters change in diabetic patients with hyperthyroidism
暂未订购
导出
摘要 目的观察合并甲状腺功能亢进(甲亢)的2型糖尿病(type 2diabetes mellitus,T2DM)患者的生化指标变化,探讨甲亢对T2DM患者的影响。方法回顾性分析72例T2DM合并甲状腺功能异常的患者(甲亢组)与140例T2DM甲状腺功能正常患者(对照组)的血糖、血脂、肾功能等变化。结果与对照组比较,甲亢组甘油三脂、总胆固醇、低密度脂蛋白胆固醇、糖化血红蛋白、肌酐降低,而两组空腹血糖、餐后两小时血糖、高密度脂蛋白胆固醇、极低密度脂蛋白及尿白蛋白/肌酐、肾小球滤过率差异均无统计学意义。结论伴有甲亢的T2DM患者虽然个别指标降低,但在糖代谢紊乱、肾脏损伤、大血管并发症方面有着同样的风险,治疗上应予以重视。 Objective To observe the biochemical markers of type 2 diabetes mellitus(T2DM)patients with hyperthyroidism,to investigate the effects of hyperthyroidism in patients with T2DM.Methods Retrospective analysis was performed in blood sugar,blood lipid,renal function and other indicators of 72 T2DM cases with thyroid function abnormality(hyperthyroidism group)and 140 T2DM with normal thyroid function (control group).Results Compared with the control group,triglyceride,total cholesterol,low density lipoprotein cholesterol,glycated hemoglobin, creatinine in hyperthyroidism group decreased, while there were no significant difference in fasting glucose, postprandial blood glucose two hours,high density lipoprotein cholesterol,very low density lipoprotein and urinary albumin/creatinine between two groups.Conclusion Although individual indicators in T2DM cases with thyroid function abnormality decreased,the patients share similar risk in glucose metabolism disorders,kidney damage, vascular complications,and attention should be paid on the treatment.
出处 《临床荟萃》 CAS 2014年第11期1236-1238,共3页 Clinical Focus
关键词 糖尿病 2型 甲状腺功能亢进症 血糖 血脂异常 肾功能试验 diabetes mellitus, type 2 hyperthyroidism blood sugar dyslipidemias kidney function tests
  • 相关文献

参考文献2

二级参考文献8

  • 1毋济霞,魏祥安,赵东波.老年人甲状腺功能亢进症糖和脂代谢特点52例分析[J].医师进修杂志,2005,28(8):41-42. 被引量:4
  • 2Canaris GJ,Manowitz NR,Mayor G,et al.The Colorado thyroid disease prevalence study[J].Arch Intern Med,2000,160(4):526-534.
  • 3Dedecjus M,Masson D,Gautier T.Low cholesteryl ester transfer protein(CETP) concentration but normal CETP activity in serum from patients with short-term hypothyroidism Lack of relationship to lipoprotein abnormalities[J].Clin Endcrinol,2003,58(5):581-588.
  • 4Sasaki S,Kawai K,Honjo Y,et al.Thyroid hormones and lipid metabolism[J].Nippon Rinsho,2006,64(12):2323-2329.
  • 5Berti JA,Amaral ME,Boschero AC.Thyroid hormone increases plasma cholesteryl ester transfer protein activity and plasma high-density lipoprotein removal rate in transgenic mice[J].Metabolism,2001,50(5):530-536.
  • 6Huesca-gomez C,Franco M,Luc G,et al.Chronic hypothyroidism induces abnormal structure of high-density lipoproteins and impaired kinetics of apolipoprotein A-L in the rat[J].Metabolism,2002,51(4):443-450.
  • 7Isaacs A,Aulchenko YS,Hofman A,et al.Epistatic effect of cholesteryl ester transfer protein and hepatic lipase on serum HDL-c levels[J].Clin Endocrinol Metab,2007,92(7):2680-2687.
  • 8陈江平,刘秀娟,陈泰祺.甲状腺功能亢进症住院患者糖代谢异常的临床研究[J].海南医学,2008,19(11):36-37. 被引量:7

共引文献40

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部